{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:03:39Z","timestamp":1760954619447},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.transproceed.2003.12.042","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T16:07:14Z","timestamp":1079712434000},"page":"S524-S527","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S","title":["Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients"],"prefix":"10.1016","volume":"36","author":[{"given":"K","family":"Budde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Glander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Dragun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Waiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-H","family":"Neumayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2003.12.042_BIB1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB4","unstructured":"Takemoto SK: In Cecka JM, Terasaki PI (eds): 16th Annual Volume Clinical Transplantations. Los Angeles, Calif.: UCLA Immunogenetics Center; 2000, p 481"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB5","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB6","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.V11122366","article-title":"Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients","volume":"11","author":"Meier-Kriesche","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil. Aetiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2003","journal-title":"Clin Transplant"},{"issue":"suppl 5","key":"10.1016\/j.transproceed.2003.12.042_BIB10","first-page":"56","article-title":"Graft survival and cost following gastrointestinal complications in renal transplant recipients treated with mycophenolate mofetil","volume":"3","author":"Hardinger","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB11","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB12","unstructured":"Ferguson RM, Porterfield-Baxa J, Tierce JC, et al: The cost of mycophenolate mofetil-related (MMF) gastrointestinal adverse events and impact of MMF dose-reductions\/discontinuations on acute rejection in transplanted patients. European Society for Organ Transplantation, Venice, Italy, 20\u201324 September 2003 (Abstract 707)"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB13","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/S0041-1345(01)02377-6","article-title":"Enteric coating of mycophenolate sodium","volume":"33","author":"Bjarnason","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB14","doi-asserted-by":"crossref","unstructured":"Schmouder R, Arns W, Merkel F, et al: Pharmacokinetics of ERL080A: a new enteric coated formulation of mycophenolic acid-sodium. 18th Annual Meeting of the American Society of Transplantation, Chicago, IL, USA, 15\u201319 May, 1999 (Abstract 787)","DOI":"10.1097\/00007890-199904150-00811"},{"issue":"suppl 3","key":"10.1016\/j.transproceed.2003.12.042_BIB15","first-page":"399","article-title":"Pharmacokinetic and pharmacodynamic comparison of mycophenolate mofetil and enteric-coated mycophenolate sodium in maintenance renal transplant patients","volume":"2","author":"Budde","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB17","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0041-1345(01)02378-8","article-title":"Enteric-coated mycophenolate sodium","volume":"33","author":"Granger","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2003.12.042_BIB18","unstructured":"Neumayer H-H, Curtis J, Panis C, et al: Tolerability and safety of enteric-coated mycophenolate sodium (EC-MPS) versus MMF in maintenance renal transplant patients. \u20182001 A Transplant Odyssey\u2014The Future is Here\u2019, Istanbul, Turkey, 20\u201323 August, 2001 (Abstract 1800)"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134503013538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134503013538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T04:49:46Z","timestamp":1623732586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134503013538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0041134503013538"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2003.12.042","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}